Company Filing History:
Years Active: 2025
Title: Innovations by Sergio Martín Pontejo
Introduction
Sergio Martín Pontejo is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for autoimmune and inflammatory diseases. His work focuses on improving existing treatments to enhance their efficacy and reduce side effects.
Latest Patents
Sergio holds a patent for "Etanercept variants with improved therapeutical effect." This invention provides improved Etanercept variants that include one (A105E) or preferably two (A105E/L106F) amino acid substitutions in the original amino acid sequence. These variants are designed to inhibit TNF activity while not neutralizing human LTα (hLTα). This innovation presents a promising alternative for clinical use in treating autoimmune or inflammatory diseases, as it minimizes the side effects associated with the original Etanercept molecule while maintaining its TNF blocking activity. He has 1 patent to his name.
Career Highlights
Sergio is affiliated with the Consejo Superior de Investigaciones Científicas, where he conducts his research and development work. His role at this prestigious research institution allows him to collaborate with other experts in the field and contribute to advancements in medical science.
Collaborations
One of his notable collaborators is Carolina Sánchez Fernández. Together, they work on innovative solutions that aim to improve patient outcomes in the realm of autoimmune and inflammatory diseases.
Conclusion
Sergio Martín Pontejo's contributions to biotechnology through his innovative patent on Etanercept variants highlight his commitment to advancing medical treatments. His work exemplifies the importance of innovation in addressing complex health challenges.